Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05753020 · ClinicalTrials.gov registry record · NA

A Pilot Study of The CKM JumpStart Tool

A NA study of Chronic Kidney Diseases, sponsored by University of Washington.

Recruiting
Registry status
NA
Development phase
76
Enrollment target
2
Study locations

NCT05753020: Recruiting NA study of Chronic Kidney Diseases, sponsored by University of Washington.

NCT05753020 is a NA study of Chronic Kidney Diseases that is actively recruiting participants, run by University of Washington. The registered enrollment target is 76 participants, below the 444-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (83% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05753020, a NA study of Chronic Kidney Diseases, is actively recruiting participants, sponsored by University of Washington.

RECRUITING
Registry status
NA
Development phase
76 participants
Enrollment target
2
Study locations

Study Summary

This is a randomized pilot study to test the feasibility and acceptability of a tool to promote discussion about conservative kidney management (CKM) among older patients with advanced CKD and their providers.

Conditions Studied

Interventions

  • BEHAVIORAL CKM Jumpstart Tool

Study Locations (2)

Washington

  • VA Puget Sound Health Care System - Seattle
  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 76 participants
Start Date 2023-04-10
Est. Completion 2025-12-31
Phase NA
University of Washington

1,048 total trials

What NCT05753020 shows while recruiting

NCT05753020 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 76 participants, a relatively small participant target, below the 444-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (83% lower).

The record links to 1 condition, with Chronic Kidney Diseases appearing as the primary indexed condition, and to 1 intervention - of which CKM Jumpstart Tool is the first listed.

NCT05753020 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT05753020 about?

NCT05753020 is a clinical study titled "A Pilot Study of The CKM JumpStart Tool". This is a randomized pilot study to test the feasibility and acceptability of a tool to promote discussion about conservative kidney management (CKM) among older patients with advanced CKD and their providers.

What is the current status of trial NCT05753020?

This trial is currently recruiting. It is a NA study. The enrollment target is 76 participants. The study started on 2023-04-10. Estimated completion is 2025-12-31.

What conditions does trial NCT05753020 study?

This clinical trial studies the following conditions: Chronic Kidney Diseases.

What interventions are being tested in trial NCT05753020?

The interventions under investigation include: CKM Jumpstart Tool (BEHAVIORAL).

Who is sponsoring clinical trial NCT05753020?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05753020 being conducted?

This trial has 2 study locations across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Kidney Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05753020's enrollment target sits among peer trials

76 44th of 73 higher than 30 of 73 other Chronic Kidney Diseases trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Kidney Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02615184 · 76 participants · Phase 2

    A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old

  • NCT02821741 · 76 participants · NA

    Effects of External Ear Stimulation on Pain Perception and Mood

  • NCT03019757 · 76 participants

    Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease

  • NCT03353584 · 76 participants · NA

    Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05753020, the US trial registry maintained by the National Library of Medicine. NCT05753020 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.